(NASDAQ: TLSA) Tiziana Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 207.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,947.47%.
Tiziana Life Sciences's earnings in 2025 is -$11,863,000.On average, 3 Wall Street analysts forecast TLSA's earnings for 2025 to be -$20,464,536, with the lowest TLSA earnings forecast at -$19,662,006, and the highest TLSA earnings forecast at -$21,066,435.
In 2026, TLSA is forecast to generate -$22,738,374 in earnings, with the lowest earnings forecast at -$21,846,673 and the highest earnings forecast at -$23,407,150.